Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

COLORS in IBD group investigators, Oxford IBD cohort study investigators, INTERVAL Study, Swiss IBD cohort investigators, UK Inflammatory Bowel Disease (IBD) Genetics Consortium, NIDDK IBD Genetics Consortium, Eva Gonçalves Serra, Tobias Schwerd, Loukas Moutsianas, Athena Cavounidis, Laura Fachal, Sumeet Pandey, Jochen Kammermeier, Nicholas M. Croft, Carsten Posovszky, Astor Rodrigues, Richard K Russell, Farah Barakat, Marcus K. H. Auth, Robert HeuschkelMatthias Zilbauer, Krzysztof Fyderek, Christian Braegger, Simon P. Travis, Jack Satsangi, Miles Parkes, Nikhil Thapar, Helen Ferry, Julie C. Matte, Kimberly C. Gilmour, Andrzej Wedrychowicz, Peter Sullivan, Carmel Moore, Jennifer Sambrook, Willem Ouwehand, David Roberts, John Danesh, Toni A. Baeumler, Tudor A. Fulga, Eli M. Carrami, Ahmed Ahmed, Rachel Wilson, Jeffrey C. Barrett, Abdul Elkadri, Anne M Griffiths, Scott B Snapper, Neil Shah, Aleixo M. Muise, David C Wilson, Holm Uhlig, Carl A Anderson, William Newman

Research output: Contribution to journalArticlepeer-review

Abstract

Very-early-onset inflammatory bowel disease (VEO-IBD) is a heterogeneous phenotype associated with a spectrum of rare Mendelian disorders. Here, we perform whole-exome-sequencing and genome-wide genotyping in 145 patients (median age-at-diagnosis of 3.5 years), in whom no Mendelian disorders were clinically suspected. In five patients we detect a primary immunodeficiency or enteropathy, with clinical consequences (XIAP, CYBA, SH2D1A, PCSK1). We also present a case study of a VEO-IBD patient with a mosaic de novo, pathogenic allele in CYBB. The mutation is present in ~70% of phagocytes and sufficient to result in defective bacterial handling but not life-threatening infections. Finally, we show that VEO-IBD patients have, on average, higher IBD polygenic risk scores than population controls (99 patients and 18,780 controls; P -10), and replicate this finding in an independent cohort of VEO-IBD cases and controls (117 patients and 2,603 controls; P -10). This discovery indicates that a polygenic component operates in VEO-IBD pathogenesis.
Original languageEnglish
Article number995
Pages (from-to)1-15
Number of pages15
JournalNature Communications
Volume11
DOIs
Publication statusPublished - 21 Feb 2020

Fingerprint

Dive into the research topics of 'Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this